Skip to main content

Image gallery






  • IBM Introduces 2014 Class of Fellows

    IBM Introduces 2014 Class of Fellows


    Date added: 2014-04-02


    IBM (NYSE: IBM) has elevated a record number of eleven scientists to the IBM Fellow honor, the company’s most prestigious technical distinction. The 2014 Fellows will be responsible for carrying out the Technology Ambassador Initiative, which is to drive growth through innovation and is directly tied to the roots of the IBM program. The Fellow honor acknowledges an IBM Researcher's important contributions and industry-leading innovations in developing some of the world's most important technologies. In the true spirit of Thomas J. Watson’s vision to give IBM fellows creative freedom and responsibility, the 2014 IBM Fellows have influenced a broad array of technologies in the following areas: Brain-inspired cognitive computing, security platforms, computational science, cloud computing, business database and analytics, and high performance, enterprise storage technologies. IBM Fellows have a history of pushing the boundaries of science and technology to deliver improved solutions for constantly changing, global business needs.  Left to Right: Krishna Ratakonda, Dharmendra Modha, Mike Haydock, Saska Mojsilovic, Alessandro Curioni, Rhonda Childress, Sandy Bird, Namik Hrle, Tamar Eilam, Andy Walls, Shivakumar Vaithyanathan  

     

     

     



  • IBM Watson NYGC for Wire

    IBM's Watson to Help Unlock Life-saving Insights from Cancer Patient DNA


    Date added: 2014-03-19


    New York, NY/March 19, 2014 - Dr. Robert Darnell (left), CEO of the New York Genome Center, and Dr. Ajay Royyuru, Director of the IBM Computational Biology Center (right) discuss how IBM's Watson will be used to make sense of vast amounts of genetic sequencing data and medical information to identify personalized treatments for cancer patients, at an event at the New York Genome Center in New York City on March 19, 2014. IBM and NYGC will soon begin testing a Watson prototype designed specifically for genomic research to help oncologists deliver unique, customized cancer treatments according to an individual patient's DNA. Photo Credit: Jon Simon/Feature Photo Service for IBM.

     

     




Previous | 6 - 10 of 59 results | Next